Stock Evaluator: Basel Medical Group Ltd (BMGL)

Basel Medical Group Ltd BMGL

$0.38 0.06 20.01%
November 20, 2026 4:00:00 PM EST November 10, 2021 Volume: 1,045,997
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Providers & Services

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, trauma, sports medicine, knee and hip replacements, sports medicine/surgery, foot/ankle surgery, and physiotherapy services, minimally invasive orthopedic procedures, as well as neurology and neurosurgical treatments. It also provides health screening, mental health, woman’s health, and general practice services. In addition, the company’s services include consultation, medical diagnosis, and medical and surgical treatments. Basel Medical Group Ltd was incorporated in 2023 and is headquartered in Singapore.

Commentary & Analysis


Financial Summary

Share Statistics BMGL Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $5.1 $1,721.2 5%
Shares Out (Mil) 1.2 80.6 6%
Institutional Ownership 11.3% 87.6% 6%
Float (Mil) 12.5 59.2 22%
Beta na 0.74 na
Avg Daily Volume (000s) 9,482 613 96%
Price Change
(52-week)
(97.8%) 74.5% 3%
Growth BMGL Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 10.4% na
Net Income (5yr) na (0.5%) na
EPS (5yr) na 3.0% na
Dividends (5yr) na 0.0% 0%
Cash Flow (5yr) na (17.4%) na
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na na
Current EPS na na na
Month Ago EPS na na na
# Rev Up na na na
# Rev Down na na na
Three Months Ago EPS na na na
Year/Year Chg na na na
Financials BMGL Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $16 $1,529 11%
Net Income (TTM) (Mil) ($1) $33 37%
EPS (TTM) ($0.365) $0.300 29%
Operating Cash Flow (TTM) (Mil) ($1) $175 31%
Net Cash Flow (TTM) (Mil) ($2) $7 40%
Long-Term Debt (Q1) (Mil) $3 $419 21%
Enterprise Value (Q1) (Mil) $6 $2,427 7%
Valuation BMGL Industry
Median
Percentile
(All Stocks)
P/B 0.15 2.56 4%
P/E na 25.9 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.1 na
Ratios BMGL Industry
Median
Percentile
(All Stocks)
Gross Margin 35.7% 27.3% 44%
Net Margin (3.6%) 1.4% 26%
ROA (4.1%) 2.4% 30%
ROE (14.1%) 7.3% 25%
Liabilities to Assets 74.5% 62.3% 70%
F-Score 6 5 67%

Basel Medical Group Ltd did not pass any screens on 11/20/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors